Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Immunology|March 29, 2002
Activation of the immune system by bacterial CpG-DNAGeorg Häcker, Vanessa Redecke, Hans Häcker
Current Opinion in Allergy and Clinical Immunology|January 11, 2005
Toll-like receptor ligands: hygiene, atopy and therapeutic implicationsAnthony A Horner, Vanessa Redecke, Eyal Raz
Immunology|March 3, 2016
SHARPIN controls the development of regulatory T cellsVanessa Redecke, Vandana Chaturvedi, Jeeba Kuriakose, et al.
Infection and Immunity|September 22, 2010
Inhibition of T cells provides protection against early invasive pneumococcal diseaseKim LeMessurier, Hans Häcker, Elaine Tuomanen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2012
NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activationHans Häcker, Liying Chi, Jerold E Rehg, et al.
Plos Pathogens|November 19, 2013
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungKim S LeMessurier, Hans Häcker, Liying Chi, et al.
Nature Methods|June 11, 2013
Hematopoietic progenitor cell lines with myeloid and lymphoid potentialVanessa Redecke, Ruiqiong Wu, Jingran Zhou, et al.
The Journal of Biological Chemistry|September 8, 2011
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activationCinthia C Stempin, Liying Chi, Juan P Giraldo-Vela, et al.
Pageof 3